Effectiveness of one and two doses of acellular pertussis vaccines against laboratory-confirmed pertussis requiring hospitalisation in infants: Results of the PERTINENT sentinel surveillance system in six EU/EEA countries, December 2015 - December 2019.

pubmed.ncbi.nlm.nih.gov

Alberto Tozzi

Monitoring effectiveness of pertussis vaccines is necessary to adapt vaccination strategies. PERTINENT, Pertussis in Infants European Network, is an active sentinel surveillance system implemented in 35 hospitals across six EU/EEA countries. We aim to measure pertussis vaccines effectiveness (VE) by dose against hospitalisation in infants aged <1 year. From December 2015 to December 2019, particip…

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Oct 2026 · 1 min read

In brief

Multi-country sentinel surveillance study measuring acellular pertussis vaccine effectiveness against hospitalization in infants under 1 year across six EU/EEA countries from 2015-2019. Provides evidence for optimizing infant pertussis vaccination schedules based on real-world protection data.

Written by the GCMD Library team from the article.

Alberto Tozzi

Read it at the source ↗